Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Aug 20, 2020 08:08AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
RBC has ZENE valued at $0.001 dollars,,,,,thats not much,,,,its actually FA!